This company listing is no longer active
Albioma Balance Sheet Health
Financial Health criteria checks 3/6
Key information
164.91%
Debt to equity ratio
€1.11b
Debt
| Interest coverage ratio | 3.5x |
| Cash | €128.84m |
| Equity | €675.43m |
| Total liabilities | €1.43b |
| Total assets | €2.10b |
Recent financial health updates
Is Albioma (EPA:ABIO) Using Too Much Debt?
Oct 18
These 4 Measures Indicate That Albioma (EPA:ABIO) Is Using Debt Extensively
Mar 25Recent updates
Returns On Capital At Albioma (EPA:ABIO) Have Stalled
Feb 27Albioma (EPA:ABIO) Has More To Do To Multiply In Value Going Forward
Nov 23Is Albioma (EPA:ABIO) Using Too Much Debt?
Oct 18Albioma's (EPA:ABIO) Returns Have Hit A Wall
Aug 19Albioma's (EPA:ABIO) Returns Have Hit A Wall
May 12Is Albioma (EPA:ABIO) Worth €39.2 Based On Its Intrinsic Value?
Apr 28These 4 Measures Indicate That Albioma (EPA:ABIO) Is Using Debt Extensively
Mar 25Is Albioma (EPA:ABIO) A High Quality Stock To Own?
Mar 07Albioma (EPA:ABIO) Has Rewarded Shareholders With An Exceptional 332% Total Return On Their Investment
Feb 18
Is Albioma (EPA:ABIO) Likely To Turn Things Around?
Jan 23What Kind Of Shareholders Own Albioma (EPA:ABIO)?
Jan 05At €43.80, Is It Time To Put Albioma (EPA:ABIO) On Your Watch List?
Dec 19A Closer Look At Albioma's (EPA:ABIO) Impressive ROE
Dec 06How Is Albioma's (EPA:ABIO) CEO Paid Relative To Peers?
Nov 22Financial Position Analysis
Short Term Liabilities: ABIO's short term assets (€376.6M) exceed its short term liabilities (€358.6M).
Long Term Liabilities: ABIO's short term assets (€376.6M) do not cover its long term liabilities (€1.1B).
Debt to Equity History and Analysis
Debt Level: ABIO's net debt to equity ratio (145.8%) is considered high.
Reducing Debt: ABIO's debt to equity ratio has reduced from 166.8% to 164.9% over the past 5 years.
Debt Coverage: ABIO's debt is not well covered by operating cash flow (14.7%).
Interest Coverage: ABIO's interest payments on its debt are well covered by EBIT (3.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/10/13 16:31 |
| End of Day Share Price | 2022/09/13 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Albioma is covered by 17 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Charles-Louis Planade | Arkeon Finance |
| Yohann Terry | BNP Paribas Exane |
| Caroline Cohen | BofA Global Research |